Share buy-back
Share buy-back 2019
On June 17, 2019 we commenced, as announced on June 14, 2019, our share buy-back program on the basis of the authorization by the Annual General Meeting 2016.
In the context of this share buy-back program, ordinary shares of Fresenius Medical Care in the total amount of €659 million (excluding fees) were repurchased in the period from June 17, 2019 until April 1, 2020. Accordingly, the share buy-back program was fully completed on April 1, 2020.
In the following we inform you about the number of shares acquired in the context of the share buy-back program.
The own shares repurchased by the Company will be used for the sole purpose of reducing the registered share capital by cancellation of the repurchased own shares.
Period | Acquired shares (number) | Average price (in €) | Purchased volume (in €) | Details (overview) |
---|---|---|---|---|
June 17-21, 2019 | 268,881 | 69.4151 | 18,539,371.60 | CW 25 |
June 24-28, 2019 | 235,791 | 68.6900 | 16,202,459.86 | CW 26 |
July 1-5, 2019 | 191,565 | 70.6451 | 13,531,851.27 | CW 27 |
July 8-12, 2019 | 234.300 | 68.9617 | 16,008,564.21 | CW 28 |
July 15-19, 2019 | 313,690 | 68.9307 | 21,482,477.74 | CW 29 |
July 22-26, 2019 | 226,354 | 67.9923 | 15,365,657.14 | CW 30 |
July 29 - August 2, 2019 | 63,746 | 65.9749 | 4,186,086.59 | CW 31 |
August 5-9, 2019 | 99,453 | 60.1077 | 5,982,894.14 | CW 32 |
August 12-16, 2019 | 297,998 | 59.3147 | 17,657,467.50 | CW 33 |
August 19-23, 2019 | 258,000 | 60.6767 | 15,677,626.01 | CW 34 |
August 26-30, 2019 | 179,757 | 60.6304 | 10,898,390.31 | CW 35 |
September 2-6, 2019 | 216,466 | 61.5136 | 13,299,110.45 | CW 36 |
September 9-13, 2019 | 238,000 | 62.5762 | 14,877,752.80 | CW 37 |
September 16-20, 2019 | 173,000 | 63.3081 | 10,951,978.68 | CW 38 |
September 23-27, 2019 | - | - | - | CW 39 |
September 30 - October 4, 2019 | - | - | - | CW 40 |
October 7-11, 2019 | 113,498 | 59.2132 | 6,746,695.83 | CW 41 |
October 14-18, 2019 | 205,025 | 60.9088 | 12,549,505.19 | CW 42 |
October 21-25, 2019 | 329,490 | 59.8711 | 19,192,556.07 | CW 43 |
October 28 - November 1, 2019 | 81,721 | 65.2578 | 5,328,059.92 | CW 44 |
November 4-8, 2019 | 177,000 | 67.8643 | 12,010,538.75 | CW 45 |
November 11-15, 2019 | 174,687 | 66.2944 | 11,580,925.97 | CW 46 |
November 18-22, 2019 | 174,731 | 66.7549 | 11,663,941.42 | CW 47 |
November 25-29, 2019 | 289,617 | 66.7641 | 19,306,343.34 | CW 48 |
December 2-6, 2019 | 186,894 | 65.7546 | 12,289,499.59 | CW 49 |
December 9-13, 2019 | 189,170 | 64.4820 | 12,886,319.87 | CW 50 |
December 16-20, 2019 | 188,844 | 65.0585 | 12,283,796.78 | CW 51 |
December 23-27, 2019 | - | - | - | CW 52 |
December 30, 2019 - January 3, 2020 | - | - | - | CW 01 |
January 6-10, 2020 | 85,000 | 65.5289 | 5,570,318.00 | CW 02 |
January 13-17, 2020 | 35,000 | 66,3875 | 2,323,563.90 | CW 03 |
January 20-24, 2020 | - | - | - | CW 04 |
January 27-31, 2020 | 4,398 | 70.95655 | 312,066.91 | CW 05 |
February 3-7, 2020 | 13,465 | 72.8522 | 980,207.25 | CW 06 |
February 10-14, 2020 | - | - | - | CW 07 |
February 17-21, 2020 | 6,456 | 74.3755 | 480,168.10 | CW 08 |
February 24-28, 2020 | 5,398 | 70.5893 | 381,040.88 | CW 09 |
March 2-6, 2020 | 4,412 | 69.9983 | 308,832.59 | CW 10 |
March 9-13, 2020 | 192,221 | 61.0700 | 11,468,490.28 | CW 11 |
March 16-20, 2020 | 449,021 | 58.0507 | 25,394,068.14 | CW 12 |
March 23-27, 2020 | 2,985,306 | 56.5034 | 168,904,012.12 | CW 13 |
March 30 - April 01, 2020 | 1,906,796 | 59.0821 | 112,673,443.72 | CW 14 |
Total | 10,795,151 | 61.0270 | 658,796,082.96 |
On March 12, 2019 we commenced, as announced on March 11, 2019, our share buy-back program on the basis of the authorization by the Annual General Meeting 2016.
In the context of this share buy-back program, ordinary shares of Fresenius Medical Care in the total amount of €270 million (excluding fees) were repurchased in the period from March 12, 2019 until May 10, 2019. Accordingly, the share buy-back program was fully completed on May 10, 2019.
In the following we inform you about the number of shares acquired in the context of the share buy-back program.
The own shares repurchased by the Company will be used for the sole purpose of reducing the registered share capital by cancellation of the repurchased own shares.
Period | Acquired shares (number) | Average price (in €) | Purchased volume (in €) | Details (overview) |
---|---|---|---|---|
March 12-15, 2019 | 550,000 | 69.36646 | 38,151,553.00 | CW 11 |
March 18-22, 2019 | 734,693 | 69.81767 | 51,294,556.71 | CW 12 |
March 25-29, 2019 | 344,547 | 70.72767 | 24,369,006.52 | CW 13 |
April 01-05, 2019 | 433,128 | 73.67726 | 31,911,683.99 | CW 14 |
April 08-12, 2019 | 497,677 | 73.72803 | 36,692,744.84 | CW 15 |
April 15-18, 2019 | 809,692 | 71.94412 | 58,252,578.36 | CW 16 |
April 23-26, 2019 | 192,031 | 71.71234 | 13,770,991.54 | CW 17 |
April 29 - May 3, 2019 | 111,494 | 74.99443 | 8,361,430.03 | CW 18 |
May 6-10, 2019 | 97,510 | 73.79218 | 7,195,475.25 | CW 19 |
Total | 3,770,772 | 71.60338 | 270,000,020.24 |
Share buy-back 2018
On May 28, 2018 we commenced, as announced on May 25, 2018, our share buy-back program on the basis of the authorization by the Annual General Meeting 2016.
In the context of this share buy-back program, ordinary shares of Fresenius Medical Care in the total amount of €37 million (excluding fees) were repurchased in the period from May 28, 2018 until June 8, 2017. Accordingly, the share buy-back program was fully completed on June 8, 2017.
In the following we inform you about the number of shares acquired in the context of the share buy-back program.
TThe own shares repurchased by the Company will be used for the sole purpose of reducing the registered share capital by cancellation of the repurchased own shares in order to neutralize the dilution from the Stock Option Plan 2011.
Period | Acquired shares (number) | Average price (in €) | Purchased volume (in €) | Details (overview) |
---|---|---|---|---|
May 28, 2018 | 43,274 | 86.8348 | 3,758,816.44 | CW 22 |
May 29, 2018 | 43,500 | 86.4675 | 3,762,464.65 | CW 22 |
May 30, 2018 | 43,500 | 87.0162 | 3,786,340.26 | CW 22 |
May 31, 2018 | 43,000 | 86.3560 | 3,714,421.99 | CW 22 |
June 1, 2018 | 44,500 | 85.1607 | 3,790,788.05 | CW 22 |
June 4, 2018 | 43,500 | 85.3555 | 3,712,964.25 | CW 23 |
June 5, 2018 | 43,500 | 86.6331 | 3,768,539.85 | CW 23 |
June 6, 2018 | 42,294 | 86.7213 | 3,667,790.66 | CW 23 |
June 7, 2018 | 42,863 | 86.7374 | 3,717,825.18 | CW 23 |
June 8, 2018 | 41,069 | 86.3573 | 3,546,607.95 | CW 23 |
Total | 431,000 | 86.3828 | 37,230,979.89 |
Share buy-back 2017
On December 11, 2017 we commenced, as announced on December 8, 2017, our share buy-back program on the basis of the authorization by the Annual General Meeting 2016.
In the context of this share buy-back program, ordinary shares of Fresenius Medical Care in the total amount of €58 million (excluding fees) were repurchased in the period from December 11, 2017 until December 21, 2017. Accordingly, the share buy-back program was fully completed on December 21, 2017. T
In the following we inform you about the number of shares acquired in the context of the share buy-back program.
The own shares repurchased by the Company will be used for the sole purpose of reducing the registered share capital by cancellation of the repurchased own shares in order to neutralize the dilution from the Stock Option Plan 2011.
Period | Acquired shares (number) | Average price (in €) | Purchased volume (in €) | Details (overview) |
---|---|---|---|---|
December 11, 2017 | 90,000 | 87.4549 | 7,870,941.00 | CW 50 |
December 12, 2017 | 89,582 | 88.0422 | 7,886,996.36 | CW 50 |
December 13, 2017 | 90,000 | 88.6892 | 7,982,028.00 | CW 50 |
December 14, 2017 | 83,993 | 87.5675 | 7,355,057.03 | CW 50 |
December 15, 2017 | 85,000 | 86.7878 | 7,376,963.00 | CW 50 |
December 18, 2017 | 74,879 | 88.2222 | 6,605,990.11 | CW 51 |
December 19, 2017 | 74,389 | 87.9080 | 6,539,388.21 | CW 51 |
December 20, 2017 | 74,403 | 87.5432 | 6,250,847.11 | CW 51 |
December 21, 2017 | 754 | 87.2622 | 65,795.70 | CW 51 |
Total | 660,000 | 87.7788 | 57,934,006.52 |
Share buy-back 2013
On May 20, 2013 we commenced, as announced on May 17, 2013, our share buy-back program on the basis of the authorization by the Annual General Meeting 2011.
In the context of this share buy-back program, ordinary shares of Fresenius Medical Care in the total amount of €385 million (excluding fees) were repurchased in the period from May 20, 2013 until August 14, 2013. Accordingly, the share buy-back program was fully completed on August 14, 2013. The program was financed from cash flow and existing credit facilities.
In the following we inform you about the number of shares acquired in the context of the share buy-back program.
The own shares acquired by the company will be used to serve the sole purposes of either reducing the registered share capital of the company by cancellation of the acquired own shares, or fulfilling employee participation programs of the company.
Period | Acquired shares (number) | Average price (in €) | Purchased volume (in €) | Details (overview) |
---|---|---|---|---|
August 12 - 14, 2013 | 184,054 | 49.6011 | 9,092,291 | KW33 |
August 5 - 9, 2013 | 556,951 | 48.2319 | 26,853,458 | KW 32 |
July 29 - August 2, 2013 | 683,469 | 47.8786 | 32,713,578 | KW 31 |
July 22 - 26, 2013 | 605,718 | 49.4679 | 29,967,517 | KW 30 |
July 15 - 19, 2013 | 597,667 | 49.8732 | 29,803,999 | KW 29 |
July 8 - 12, 2013 | 674,990 | 49.4151 | 33,329,905 | KW 28 |
July 1 - 5, 2013 | 665,295 | 50.2787 | 33,288,492 | KW 27 |
June 24 - 28, 2013 | 646,000 | 53.9658 | 34,859,615 | KW 26 |
June 17 - 21, 2013 | 580,752 | 53.2386 | 30,934,815 | KW 25 |
June 10 - 14, 2013 | 642,038 | 52.9178 | 33,974,663 | KW 24 |
June 3 - 7, 2013 | 633,762 | 52.0384 | 32,976,696 | KW 23 |
May 27 - 31, 2013 | 582,730 | 52.7636 | 30,728,800 | KW 22 |
May 20 - 24, 2013 | 495,525 | 53.1082 | 26,360,719 | KW 21 |
Total | 7,548,951 | 51.00 | 384,884,547 |